Ligand-induced Vascular Endothelial Growth Factor Receptor-3 (VEGFR-3) Heterodimerization with VEGFR-2 in Primary Lymphatic Endothelial Cells Regulates Tyrosine Phosphorylation Sites-Reference-Cited by-同舟云学术

Ligand-induced Vascular Endothelial Growth Factor Receptor-3 (VEGFR-3) Heterodimerization with VEGFR-2 in Primary Lymphatic Endothelial Cells Regulates Tyrosine Phosphorylation Sites

Published:2003-10 Issue:42 Volume:278 Page:40973-40979
ISSN:0021-9258
Container-title:Journal of Biological Chemistry
language:en
Short-container-title:Journal of Biological Chemistry

Author:

Dixelius Johan,Mäkinen Taija,Wirzenius Maria,Karkkainen Marika J.,Wernstedt Christer,Alitalo Kari,Claesson-Welsh Lena

Publisher

Elsevier BV

Subject

Cell Biology,Molecular Biology,Biochemistry

Reference35 articles.

1. Cardiovascular Failure in Mouse Embryos Deficient in VEGF Receptor-3

2. Expression of Vascular Endothelial Growth Factor Receptors 1, 2, and 3 in Quiescent Endothelia

3. Lymphatic endothelial regulation, lymphoedema, and lymph node metastasis

4. Inhibition of lymphangiogenesis with resulting lymphedema in transgenic mice expressing soluble VEGF receptor-3

5. VEGF-C induced lymphangiogenesis is associated with lymph node metastasis in orthotopic MCF-7 tumors

Cited by 219 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Targeting lymphatic function in cardiovascular-kidney-metabolic syndrome: preclinical methods to analyze lymphatic function and therapeutic opportunities;Frontiers in Cardiovascular Medicine;2024-06-10

2. Recent advances and future directions on small molecule VEGFR inhibitors in oncological conditions;European Journal of Medicinal Chemistry;2024-06

3. Research Progress in Targeted Therapy for Esophageal Cancer;Journal of Biosciences and Medicines;2024

4. SAR131675 exhibits anticancer activity on human ovarian cancer cells through inhibition of VEGFR-3/ERK1/2/AKT signaling pathway;Cellular Signalling;2023-11

5. Traitements personnalisés des lymphœdèmes primaires guidés par la génétique ou innovation thérapeutique;La Presse Médicale Formation;2023-10